MGC Pharmaceuticals Total Debt vs. Cash And Equivalents

MGCLFDelisted Stock  USD 0.21  0.00  0.00%   
Based on MGC Pharmaceuticals' profitability indicators, MGC Pharmaceuticals may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess MGC Pharmaceuticals' ability to earn profits and add value for shareholders.
For MGC Pharmaceuticals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of MGC Pharmaceuticals to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well MGC Pharmaceuticals utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between MGC Pharmaceuticals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of MGC Pharmaceuticals over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Please note, there is a significant difference between MGC Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if MGC Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MGC Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

MGC Pharmaceuticals Cash And Equivalents vs. Total Debt Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining MGC Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare MGC Pharmaceuticals value to that of its competitors to determine the firm's financial worth.
MGC Pharmaceuticals is regarded second in total debt category among its peers. It is regarded fourth in cash and equivalents category among its peers creating about  0.43  of Cash And Equivalents per Total Debt. The ratio of Total Debt to Cash And Equivalents for MGC Pharmaceuticals is roughly  2.30 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the MGC Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

MGC Total Debt vs. Competition

MGC Pharmaceuticals is regarded second in total debt category among its peers. Total debt of Drug Manufacturers—Specialty & Generic industry is now estimated at about 115.26 Million. MGC Pharmaceuticals holds roughly 4.35 Million in total debt claiming about 4% of equities under Drug Manufacturers—Specialty & Generic industry.
Total debt  Revenue  Capitalization  Valuation  Workforce

MGC Cash And Equivalents vs. Total Debt

Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

MGC Pharmaceuticals

Total Debt

 = 

Bonds

+

Notes

 = 
4.35 M
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

MGC Pharmaceuticals

Cash

 = 

Bank Deposits

+

Liquidities

 = 
1.89 M
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).

MGC Cash And Equivalents Comparison

MGC Pharmaceuticals is currently under evaluation in cash and equivalents category among its peers.

MGC Pharmaceuticals Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in MGC Pharmaceuticals, profitability is also one of the essential criteria for including it into their portfolios because, without profit, MGC Pharmaceuticals will eventually generate negative long term returns. The profitability progress is the general direction of MGC Pharmaceuticals' change in net profit over the period of time. It can combine multiple indicators of MGC Pharmaceuticals, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
MGC Pharmaceuticals Limited, a bio-pharma company, develops and supplies phytomedicines in worldwide. MGC Pharmaceuticals Limited was founded in 2014 and is based in West Perth, Australia. Mgc Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.

MGC Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on MGC Pharmaceuticals. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of MGC Pharmaceuticals position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the MGC Pharmaceuticals' important profitability drivers and their relationship over time.

Use MGC Pharmaceuticals in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if MGC Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MGC Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

MGC Pharmaceuticals Pair Trading

MGC Pharmaceuticals Pair Trading Analysis

The ability to find closely correlated positions to MGC Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace MGC Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back MGC Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling MGC Pharmaceuticals to buy it.
The correlation of MGC Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as MGC Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if MGC Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for MGC Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your MGC Pharmaceuticals position

In addition to having MGC Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Recreation Thematic Idea Now

Recreation
Recreation Theme
Companies involved in production and services of recreational goods, foods, and accessories. The Recreation theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Recreation Theme or any other thematic opportunities.
View All  Next Launch
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Consideration for investing in MGC OTC Stock

If you are still planning to invest in MGC Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MGC Pharmaceuticals' history and understand the potential risks before investing.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences